课题基金 / 基金详情

CHARACTERIZATION OF TUMORS AND TIL FROM TUMORS INDUCED BY HHV-6

CHARACTERIZATION OF TUMORS AND TIL FROM TUMORS INDUCED BY HHV-6
HHV-6 诱导的肿瘤和 TIL 的特征
批准号:
3804729
负责人:
R PURI
金额:
$0.0万
依托单位:
--
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

R PURI的其他基金

相似基金

相关文献

中文摘要
翻译
我们已经发表的结果表明,由HHV-6 DNA诱导的肿瘤 在具有免疫活性的NIH-瑞士小鼠中是致瘤性的,并且肿瘤特异性TIL 可以从这些肿瘤中产生。 NIH Swiss的转移潜力 目前正在研究衍生肿瘤。 由于NIH瑞士小鼠是 远系繁殖的小鼠,我们目前也在进行研究, 将HHV-6 DNA转染Balb/C或C57 BL/6小鼠, 细胞 从近交系小鼠产生肿瘤和TIL将是必要的 在尝试体内鉴定肿瘤相关抗原之前, 体外 这个项目仍然活跃。
英文摘要
We have published results which indicated that tumors induced by HHV-6 DNA are tumorigenic in immunocompetent NIH-Swiss mice and tumor specific TIL can be generated from these tumors. The metastatic potential of NIH Swiss derived tumor is currently being studied. Since NIH Swiss mice are outbred mice, we are also currently pursuing our research to generate tumors by transfecting HHV-6 DNA into Balb/C or C57BL/6 mice-derived cells. Generation of tumors and TILs from inbred mice will be necessary before attempts are made to identify tumor associated antigens in vivo and in vitro. This project is still active.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
IL-4 RECEPTORS ON MURINE SOLID TUMORS AND TUMOR INFILTRATING LYMPHOCYTES
  • 批准号:
    3804728
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    R PURI
  • 依托单位:
    --
EFFECT OF IFN-ALPHA AND IL-2 ON IN-VIVO GENERATION OF KILLER CELLS
  • 批准号:
    3811184
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    R PURI
  • 依托单位:
    --
INTERLEUKINS AND THEIR RECEPTORS IN TUMOR BIOLOGY AND AIDS
  • 批准号:
    6161309
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    R PURI
  • 依托单位:
    --
INTERLEUKINS AND THEIR RECEPTORS IN TUMOR BIOLOGY AND AIDS
  • 批准号:
    2568987
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    R PURI
  • 依托单位:
    --
海外基金